Calidi Biotherapeutics (CLDWW) Q4 2024 Earnings

12NovConfirmed
Q3 2024
Q4 2024
-1.45
-1.18
-0.92
-0.65

Details

Expected EPS
-0.8555
Actual EPS
-0.65
Surprise EPS
0.21
Surprise Percent
+24.02%

Description

Calidi Biotherapeutics (CLDWW) has reported earnings of -0.65 per share for Q4 2024.

0 Comments

Share your thoughts